XTL BIOPHARMACEUTICALS LTD (XTLB) AI Dilution Summary

XTLB's estimated cash was $1,063,500 as of 2026-06-30, rolled forward from $76,000 at 2025-12-31 against estimated monthly burn of $85,417. Its most recent capital raised was $1,500,000 net in a private placement closed 2026-06-30 alongside the Psyga Bio acquisition: 555,555 ADSs at US$2.70 per ADS with Series A and Series B warrants.